Biopharmaceutical company immatics biotechnologies GmbH has received EUR 40m in a second round of financing from a consortium of investors. This includes previous investors Wellington Partners and 3i, but also new investors National Technology Enterprises Company and Kfw and lead investor Dietmar Hopp. This is the largest private biotech financing round in Germany since 2001.
Fund has raised €1bn of its €1.1bn target and plans to hold a final close in Q1 2020
Horizon expects to merge the two IT services providers to create a business with 300 developers
EQT deploys capital from its EQT VIII fund, which hit its €10.75bn hard-cap in 2018
Firm is investing from Paine Schwartz Food Chain Fund IV, which closed on $893m in 2014